Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alternativeName |
Uplyso
taliglucerase alfa |
| gptkbp:approvalYear |
2012
|
| gptkbp:ATCCode |
A16AB10
|
| gptkbp:form |
powder for solution for infusion
|
| gptkbp:genericName |
taliglucerase alfa
|
| https://www.w3.org/2000/01/rdf-schema#label |
Elelyso
|
| gptkbp:indication |
lysosomal storage disorder
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:mechanismOfAction |
enzyme replacement therapy
|
| gptkbp:origin |
recombinant DNA technology
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:producedBy |
carrot cells
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
headache
arthralgia upper respiratory tract infection infusion-related reactions |
| gptkbp:usedFor |
gptkb:Gaucher_disease_type_1
|
| gptkbp:bfsParent |
gptkb:Cerezyme
|
| gptkbp:bfsLayer |
7
|